Bone Biologics Corp Stock Market Value
| BBLGW Stock | USD 40.00 9.65 31.80% |
| Symbol | Bone |
Bone Biologics Corp Price To Book Ratio
Is Bone Biologics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bone Biologics. If investors know Bone will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bone Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.14) | Return On Assets (0.96) | Return On Equity (2.02) |
The market value of Bone Biologics Corp is measured differently than its book value, which is the value of Bone that is recorded on the company's balance sheet. Investors also form their own opinion of Bone Biologics' value that differs from its market value or its book value, called intrinsic value, which is Bone Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bone Biologics' market value can be influenced by many factors that don't directly affect Bone Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bone Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bone Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bone Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Bone Biologics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bone Biologics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bone Biologics.
| 06/26/2022 |
| 05/16/2024 |
If you would invest 0.00 in Bone Biologics on June 26, 2022 and sell it all today you would earn a total of 0.00 from holding Bone Biologics Corp or generate 0.0% return on investment in Bone Biologics over 690 days. Bone Biologics is related to or competes with Bone Biologics, and Inspira Technologies. Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinan... More
Bone Biologics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bone Biologics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bone Biologics Corp upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 17.46 | |||
| Information Ratio | 0.1912 | |||
| Maximum Drawdown | 105.47 | |||
| Value At Risk | (24.00) | |||
| Potential Upside | 39.28 |
Bone Biologics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bone Biologics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bone Biologics' standard deviation. In reality, there are many statistical measures that can use Bone Biologics historical prices to predict the future Bone Biologics' volatility.| Risk Adjusted Performance | 0.1326 | |||
| Jensen Alpha | 3.66 | |||
| Total Risk Alpha | 1.19 | |||
| Sortino Ratio | 0.1955 | |||
| Treynor Ratio | (1.68) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bone Biologics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bone Biologics Corp Backtested Returns
Bone Biologics is relatively risky given 3 months investment horizon. Bone Biologics Corp secures Sharpe Ratio (or Efficiency) of 0.24, which signifies that the company had a 0.24% return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 4.27% are justified by taking the suggested risk. Use Bone Biologics Risk Adjusted Performance of 0.1326, mean deviation of 11.22, and Downside Deviation of 17.46 to evaluate company specific risk that cannot be diversified away. Bone Biologics holds a performance score of 18 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -2.08, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Bone Biologics are expected to decrease by larger amounts. On the other hand, during market turmoil, Bone Biologics is expected to outperform it. Use Bone Biologics treynor ratio, as well as the relationship between the semi variance and rate of daily change , to analyze future returns on Bone Biologics.
Auto-correlation | -0.45 |
Modest reverse predictability
Bone Biologics Corp has modest reverse predictability. Overlapping area represents the amount of predictability between Bone Biologics time series from 26th of June 2022 to 6th of June 2023 and 6th of June 2023 to 16th of May 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bone Biologics Corp price movement. The serial correlation of -0.45 indicates that just about 45.0% of current Bone Biologics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.45 | |
| Spearman Rank Test | -0.53 | |
| Residual Average | 0.0 | |
| Price Variance | 60.27 |
Bone Biologics Corp lagged returns against current returns
Autocorrelation, which is Bone Biologics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bone Biologics' stock expected returns. We can calculate the autocorrelation of Bone Biologics returns to help us make a trade decision. For example, suppose you find that Bone Biologics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Bone Biologics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bone Biologics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bone Biologics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bone Biologics stock over time.
Current vs Lagged Prices |
| Timeline |
Bone Biologics Lagged Returns
When evaluating Bone Biologics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bone Biologics stock have on its future price. Bone Biologics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bone Biologics autocorrelation shows the relationship between Bone Biologics stock current value and its past values and can show if there is a momentum factor associated with investing in Bone Biologics Corp.
Regressed Prices |
| Timeline |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bone Biologics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bone Biologics' short interest history, or implied volatility extrapolated from Bone Biologics options trading.
Pair Trading with Bone Biologics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bone Biologics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bone Biologics will appreciate offsetting losses from the drop in the long position's value.Moving together with Bone Stock
| 0.64 | SGHT | Sight Sciences | PairCorr |
Moving against Bone Stock
| 0.88 | LIXTW | Lixte Biotechnology | PairCorr |
| 0.87 | RVPHW | Reviva Pharmaceuticals | PairCorr |
| 0.87 | RVPH | Reviva Pharmaceuticals Financial Report 20th of May 2024 | PairCorr |
| 0.79 | TELA | Tela Bio | PairCorr |
| 0.78 | MOLN | Molecular Partners | PairCorr |
The ability to find closely correlated positions to Bone Biologics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bone Biologics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bone Biologics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bone Biologics Corp to buy it.
The correlation of Bone Biologics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bone Biologics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bone Biologics Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bone Biologics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Bone Biologics Correlation, Bone Biologics Volatility and Bone Biologics Alpha and Beta module to complement your research on Bone Biologics. Note that the Bone Biologics Corp information on this page should be used as a complementary analysis to other Bone Biologics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for Bone Stock analysis
When running Bone Biologics' price analysis, check to measure Bone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bone Biologics is operating at the current time. Most of Bone Biologics' value examination focuses on studying past and present price action to predict the probability of Bone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bone Biologics' price. Additionally, you may evaluate how the addition of Bone Biologics to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |
Bone Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.